Nuclear Solutions Files International Patent Application for New Tritiated Water Clean-Up Process


WASHINGTON, D.C., June 23, 2005 (PRIMEZONE) -- Nuclear Solutions, Inc. (OTCBB:NSOL) announced today that it filed the first international patent application for a new patent-pending process to remediate tritiated water.

Previously the company reported that it received clearance by the U.S. government for foreign filing of this first patent after an extensive level-three national security review.

"I am ecstatic to report that we recently filed this new international patent application after receiving clearance from the U.S. government to do so," said, Patrick Herda, CEO of Nuclear Solutions. "The patent application we filed under the auspices of the Patent Cooperation Treaty (PCT) and the World Intellectual Property Organization (WIPO), allows us to simultaneously seek intellectual property protection in over one hundred countries throughout the world.

"The PCT system streamlines the process and makes it easier to obtain patent protection in foreign countries. This works to our advantage since the need to clean up tritium-contaminated water is not limited to the United States alone. Having foreign patents in place and protecting our unique ideas internationally can open up more opportunities for us to sell our process."

Additional information about the Patent Cooperation Treaty may be found at the Web site of the World Intellectual Property Organization at http://www.wipo.int/pct/en/

Tritium, a radioactive isotope, has a half-life of only 12.3 years, but its presence in wastewater poses a significant health risk because it is absorbed into environmental systems like ordinary water. Large quantities of tritium are produced as a byproduct of nuclear power plant operations and nuclear weapons complex activities. The ingestion of tritiated water can result in radiation-induced damage to chromosomes within cell nuclei. While researchers differ about the relative dangers of exposure to high levels of tritium, several studies have linked high tritium discharges to cancers and birth deformities.

About Nuclear Solutions, Inc.:

Nuclear Solutions, based in Washington, D.C., is an emerging innovative technology development company. We are committed to exploring, developing, and commercializing viable product technologies that will enable partner companies to offer new and improved products in the following areas:

Nuclear Weapon Detection for Homeland Security & Defense:

The development of advanced technology to detect shielded nuclear materials and terrorist nuclear weapons.

Nanotechnology/MEMS applications:

The development of long-lived nuclear micro-power sources, based on three U.S. Patents (5,087,533; 6,118,204; 6,238,812), to power applications in the emerging field of Nanotechnology, Micro-Electro-Mechanical Systems, and the new generation of low power microelectronics.

Environmental Technology:

Development of a patent pending process to remediate tritiated water via an advanced separation technique.

More information about Nuclear Solutions, Inc. may be found on its Web site, www.nuclearsolutions.com.

Disclaimer: The matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties such as our plans, objectives, expectations and intentions. You can identify these statements by our use of words such as "may," "when," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," "planning," "potentially," "would," or other similar words or phrases. Some of these statements include discussions regarding our future business strategy and our ability to generate revenue, income, and cash flow. Additional funding is required to develop the technology described herein. The actual future results for the Company could differ significantly from those statements. Factors that could adversely affect actual results and performance include, among others, the Company's limited operating history, dependence on key management, financing requirements, technical difficulties commercializing any projects, government regulation, technological change, and competition. In any event, undue reliance should not be placed on any forward-looking statements, which apply only as of the date of this press release. Additionally, patent-pending status does not guarantee that a patent will issue or that the technology will be commercially successful. Accordingly, reference should be made to the Company's periodic filings with the U.S. Securities and Exchange Commission.



            

Contact Data